- Home
- CVKD vs WLGS Comparison
CVKD vs WLGS Comparison
Compare CVKD & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- WLGS
- Stock Information
- Founded
- CVKD 2022
- WLGS 1981
- Country
- CVKD United States
- WLGS Hong Kong
- Employees
- CVKD N/A
- WLGS N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- WLGS Engineering & Construction
- Sector
- CVKD Health Care
- WLGS Consumer Discretionary
- Exchange
- CVKD Nasdaq
- WLGS Nasdaq
- Market Cap
- CVKD 29.5M
- WLGS 4.4M
- IPO Year
- CVKD 2023
- WLGS 2023
- Fundamental
- Price
- CVKD $12.71
- WLGS $0.06
- Analyst Decision
- CVKD Strong Buy
- WLGS
- Analyst Count
- CVKD 1
- WLGS 0
- Target Price
- CVKD $32.00
- WLGS N/A
- AVG Volume (30 Days)
- CVKD 36.2K
- WLGS 67.6M
- Earning Date
- CVKD 08-06-2025
- WLGS 08-14-2025
- Dividend Yield
- CVKD N/A
- WLGS N/A
- EPS Growth
- CVKD N/A
- WLGS N/A
- EPS
- CVKD N/A
- WLGS N/A
- Revenue
- CVKD N/A
- WLGS $3,951,649.00
- Revenue This Year
- CVKD N/A
- WLGS N/A
- Revenue Next Year
- CVKD N/A
- WLGS N/A
- P/E Ratio
- CVKD N/A
- WLGS N/A
- Revenue Growth
- CVKD N/A
- WLGS N/A
- 52 Week Low
- CVKD $5.70
- WLGS $0.03
- 52 Week High
- CVKD $22.90
- WLGS $9.66
- Technical
- Relative Strength Index (RSI)
- CVKD 49.98
- WLGS 35.41
- Support Level
- CVKD $11.00
- WLGS $0.04
- Resistance Level
- CVKD $13.56
- WLGS $0.05
- Average True Range (ATR)
- CVKD 1.15
- WLGS 0.01
- MACD
- CVKD 0.25
- WLGS 0.01
- Stochastic Oscillator
- CVKD 80.97
- WLGS 60.45
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.